The REDEFINE clinical trial program has established that: Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly produces superior weight loss compared to either agent alone The combination achieved 22.7% mean weight reduction at 68 weeks Side effect profiles were manageable with proper dose escalation The amylin + GLP-1 agonist combination demonstrated synergistic effects This validated combination demonstrates that pairing cagrilintide with incretin-based therapies can work effectively
04 Reliable Supply Consistent availability with fast delivery across Costa Rica
Most peptides retain 90-95% potency at 28 days, dropping to 80-85% by 60 days
We serve patients from Frederick MD, Mt Pleasant MD, Braddock Heights MD, Walkersville MD, Lewistown MD, Urbana MD, Ballenger Creek MD, and surrounding areas
Tortuous, immature and unevenly perfused vessels create spatial heterogeneity in vascular access, oxygenation, acidity and drug distribution [11, 12, 15, 68]